Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label follow-up study of GH-treated Prader-Willi syndrome patients from trial B9R-HL-GDDV
2007-000469-39Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of somatropin in Prader-Willi syndrome (PWS), sponsored by Eli Lilly and Company. Primary endpoint: Adult height measurement. Started Feb 2007; status: completed.
02
Drugs
somatropin
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on 2007-000469-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000469-39.